BridgeMD
New treatment option for Hearing Loss, Adult-Onset
Official title Cochlear Implant Speech in Noise Processing
ClinicalTrials.gov ID: NCT06860152
What this study is testing
- What it's testing
- The study will help us in understanding the neural mechanisms by which listeners with a cochlear implant detect speech in noisy environments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Cochlear Implant people (enrollment is planned at N=120) -
- Between 18 and 99 years of age.
- Have a cochlear implant activated for more than one year.
- Eligible for research under the Iowa Cochlear Implant Project VIII.
- Ability to understand and willingness to sign a written informed consent document.
You likely can't join if
- (all groups):
- Medical history includes seizure disorder, head injury, neurologic, metabolic, cardiovascular disease, or previous cerebrovascular event (unless...
- Female self-reporting pregnancy. A urine pregnancy test will be performed prior to injection of the radiopharmaceutical.
- Currently taking medications which may affect cerebral blood flow (e.g., papaverine, ginkgo biloba, acetazolamide).
- Uncontrolled intercurrent illness that would limit compliance with study requirements per investigator.
See the full eligibility criteria
- Cochlear Implant people (enrollment is planned at N=120) -
- Between 18 and 99 years of age.
- Have a cochlear implant activated for more than one year.
- Eligible for research under the Iowa Cochlear Implant Project VIII.
- Ability to understand and willingness to sign a written informed consent document.
- Severe hearing loss after age 16. Normal Hearing people (enrollment is planned at N=30) -
- Between 18 and 99 years of age.
- Have age typical hearing.
- Eligible for research under the Iowa Cochlear Implant Project VIII.
- Ability to understand and willingness to sign a written informed consent document.
- (all groups):
- Medical history includes seizure disorder, head injury, neurologic, metabolic, cardiovascular disease, or previous cerebrovascular event (unless approved by PI).
- Female self-reporting pregnancy. A urine pregnancy test will be performed prior to injection of the radiopharmaceutical.
- Currently taking medications which may affect cerebral blood flow (e.g., papaverine, ginkgo biloba, acetazolamide).
- Uncontrolled intercurrent illness that would limit compliance with study requirements per investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.